Skip to content
Medical Health Aged Care, National News Current Affairs

ADA Tasmania backs strengthened vaping legislation in Tasmania

ADA Tasmania < 1 mins read

ADA Tasmania backs strengthened

Vaping Legislation in Tasmania

 

Statement by ADA Tasmania President Dr Katelyn McCracken

The Australian Dental Association Tasmania Branch commends the Tasmanian Government on its plans to introduce legislation continuing the requirement for all adults to have a doctor’s prescription to purchase vaping devices, and banning the purchase of these devices for all minors under 18.

Harmful substances have been found in e-cigarette liquids and the vapours produced, which could increase the risk of lung disease, heart disease and cancer. Initial research also suggests that vaping has adverse effects on the mouth, including fungal infections, dental caries, periodontal disease and oral injuries.

Furthermore, there is not sufficient evidence that e-cigarettes are an effective smoking cessation tool. In fact, people who take up the use of e-cigarettes are around three times more likely to take up smoking, and former smokers who use e-cigarettes are more likely to relapse.

The passing of this legislation by the Tasmanian Government will restrict the availability of vaping devices and ensure that use of these devices is guided by medical professionals, which gives them suitable opportunity to provide advice regarding smoking and vaping cessation.

The legislation will also reduce access to these devices for minors, reducing the chance of creating a new generation of people with nicotine addiction as well as reducing the future burden of the currently unknown long-term health impacts of vaping.

We are encouraged that Guy Barnett and the Tasmanian Government is listening to the advice of health professionals including dentists, to protect the public from the harms of e-cigarettes, and we call on all political parties to support this necessary reform.

For further information about vaping visit https://www.health.tas.gov.au/vaping.

For media inquiries, contact ADA Tasmania President

Dr Katelyn McCracken on 0459 716 146

Email: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.